AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28675077 — intervention group
Group type: EXPERIMENTAL
Intervention: Role of school nurses in RCTs
Number of subjects: 0
Study 26899390 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental vapour ablation
Number of subjects: 70
Study 26899390 — intervention group
Group type: COMPARATOR
Intervention: Standard medical management
Number of subjects: 70
Study 25204320 — intervention group
Group type: EXPERIMENTAL
Intervention: SWITCH intervention (n=127)
Number of subjects: 251
Study 25204320 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=124)
Number of subjects: 251
Study 22902937 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill program without body weight support at a comfortable speed
Number of subjects: 22
Study 22902937 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (three sets of exercises with mat activities, balance, gait training, and functional gross motor activities)
Number of subjects: 22
Study 21044773 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil treatment
Number of subjects: 3748
Study 21044773 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 3748
Study 17239689 — intervention group
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine
Number of subjects: 0
Study 17239689 — intervention group
Group type: COMPARATOR
Intervention: Meta-analyses
Number of subjects: 0
Study 15734707 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A-fortified coconut cooking oil
Number of subjects: 542
Study 15734707 — intervention group
Group type: COMPARATOR
Intervention: Unfortified cooking oil
Number of subjects: 542
Study 15734707 — intervention group
Group type: COMPARATOR
Intervention: No cooking oil ration
Number of subjects: 542
Study 12139210 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral solution (2 g metamizole)
Number of subjects: 19
Study 12139210 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampoules (2 g metamizole)
Number of subjects: 19
Study 12139210 — intervention group
Group type: COMPARATOR
Intervention: Capsules (reference)
Number of subjects: 19
Study 10460199 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal oral fat load test (OFLT) at 2200 h
Number of subjects: 9
Study 10460199 — intervention group
Group type: COMPARATOR
Intervention: Diurnal oral fat load test (OFLT) at 0700 h
Number of subjects: 9
Study 7791836 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (10-g intramuscular loading dose followed by 5 g every four hours; additional 4-g loading dose intravenously for severe preeclampsia)
Number of subjects: 2138
Study 7791836 — intervention group
Group type: COMPARATOR
Intervention: Phenytoin (1000-mg loading dose infused over 1 hour, followed by 500-mg oral dose 10 hours later)
Number of subjects: 2138
Study 2215101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg propofol
Number of subjects: 60
Study 2215101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 mg/kg propofol
Number of subjects: 60
Study 2215101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 mg/kg propofol
Number of subjects: 60
Study 2215101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 mg/kg propofol
Number of subjects: 60
Study 2215101 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.8 mg/kg propofol
Number of subjects: 60
Study 2215101 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg propofol
Number of subjects: 60
Study 343408 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mgs of diazepam (for patients <60 years) and 5 mgs (for patients >60 years)
Number of subjects: 771
Study 343408 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam (1-2 mgs)
Number of subjects: 771
Study 343408 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedication with diazepam
Number of subjects: 771
Study 343408 — intervention group
Group type: EXPERIMENTAL
Intervention: Premedication and endoscopy
Number of subjects: 771
Study 31043662 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left dlPFC
Number of subjects: 22
Study 31043662 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 22
Study 27633341 — intervention group
Group type: EXPERIMENTAL
Intervention: Active pharmacotherapies (specifics not provided)
Number of subjects: 1236
Study 27633341 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1236
Study 25881872 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of piperacillin/tazobactam (11.25g/day on Day 1 followed by 9g/day)
Number of subjects: 16
Study 25881872 — intervention group
Group type: COMPARATOR
Intervention: Intermittent bolus (IB) administration of piperacillin/tazobactam (11.25g/day on Day 1 followed by 9g/day)
Number of subjects: 16
Study 25881872 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of piperacillin
Number of subjects: 16
Study 23670667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic Fibrosis Questionnaire-Revised (CFQ-R) - Physical domain
Number of subjects: 333
Study 23670667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystic Fibrosis Questionnaire-Revised (CFQ-R) - Psychosocial domains
Number of subjects: 333
Study 23670667 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical variables (FEV1, exacerbation frequency, weight)
Number of subjects: 333
Study 21872209 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery graft
Number of subjects: 726
Study 21872209 — intervention group
Group type: COMPARATOR
Intervention: Saphenous vein graft
Number of subjects: 726
Study 19042058 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamins E, C, and/or beta-carotene)
Number of subjects: 134590
Study 19042058 — intervention group
Group type: EXPERIMENTAL
Intervention: Single antioxidant supplementation
Number of subjects: 134590
Study 19042058 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of antioxidants
Number of subjects: 134590
Study 19042058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134590
Study 17719703 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate oral feeding
Number of subjects: 60
Study 17719703 — intervention group
Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 60
Study 15113366 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-day sequential therapy with rabeprazole 20 mg b.d. plus amoxicillin 1 g b.d. for the first 5 days, followed by rabeprazole 20 mg b.d., clarithromycin 250 mg b.d. and tinidazole 500 mg b.d. (low-dose therapy)
Number of subjects: 162
Study 15113366 — intervention group
Group type: COMPARATOR
Intervention: 10-day sequential therapy with rabeprazole 20 mg b.d. plus amoxicillin 1 g b.d. for the first 5 days, followed by rabeprazole 20 mg b.d., clarithromycin 500 mg b.d. (high-dose therapy)
Number of subjects: 162
Study 11552293 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous endometrial coculture (n = 134)
Number of subjects: 216
Study 11552293 — intervention group
Group type: COMPARATOR
Intervention: Classic IVF (control group) (n = 82)
Number of subjects: 216
Study 9846802 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental rubber dam (DRD)
Number of subjects: 22
Study 9846802 — intervention group
Group type: COMPARATOR
Intervention: Expanded polytetrafluoroethylene (e-PTFE)
Number of subjects: 22
Study 7838336 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior fossa reconstruction (PFR)
Number of subjects: 10
Study 7838336 — intervention group
Group type: COMPARATOR
Intervention: Control group (classic approach)
Number of subjects: 10
Study 7838336 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 10
Study 3048102 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (150 mg/day)
Number of subjects: 46
Study 31913072 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning method using Inception-v3 architecture CNN model on corticomedullary phase images
Number of subjects: 159
Study 31913072 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning method using CNN models on different CT phases
Number of subjects: 159
Study 31913072 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression analysis
Number of subjects: 159
Study 29718931 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit with reminders
Number of subjects: 138
Study 29718931 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit with goal setting
Number of subjects: 138
Study 29718931 — intervention group
Group type: COMPARATOR
Intervention: Fitbit only
Number of subjects: 138
Study 27340879 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol intake (≥30 g alcohol/day)
Number of subjects: 120852
Study 27340879 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary folate intake
Number of subjects: 120852
Study 27340879 — intervention group
Group type: EXPERIMENTAL
Intervention: Strata according to methylation index
Number of subjects: 120852
Study 27340879 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol and dietary folate intake interaction
Number of subjects: 120852
Study 25914483 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic group (cefuroxime 1.5 g iv half an hour before and 6 h after surgery)
Number of subjects: 409
Study 25914483 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotics)
Number of subjects: 409
Study 24434093 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged exposure psychotherapy
Number of subjects: 283
Study 24434093 — intervention group
Group type: COMPARATOR
Intervention: Present-centered psychotherapy
Number of subjects: 283
Study 20649626 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (145 mg/day)
Number of subjects: 15
Study 20649626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 19213352 — intervention group
Group type: EXPERIMENTAL
Intervention: Pishen Bingbu Recipe (PBR)
Number of subjects: 50
Study 19213352 — intervention group
Group type: COMPARATOR
Intervention: Control group (mecobalamin, vitamin B1, neurotropin, occipital-jaw band traction)
Number of subjects: 50
Study 16823368 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional fencers at 40%, 60%, and 80% of Pmax
Number of subjects: 24
Study 16823368 — intervention group
Group type: COMPARATOR
Intervention: Sedentary subjects at varying workloads (20%, 40%, 60%, 80% of Pmax)
Number of subjects: 24
Study 16823368 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional fencers at rest
Number of subjects: 24
Study 16823368 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional fencers under physical load
Number of subjects: 24
Study 16823368 — intervention group
Group type: COMPARATOR
Intervention: Sedentary subjects under physical load
Number of subjects: 24
Study 12791813 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox
Number of subjects: 70
Study 11677198 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinylestradiol (0.01 mg) plus norethisterone (2 mg) (1 tablet/d)
Number of subjects: 72
Study 11677198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 tablet/d)
Number of subjects: 72
Study 9126796 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics (spironolactone 100-400 mg/day and furosemide 80-320 mg/day)
Number of subjects: 26
Study 9126796 — intervention group
Group type: COMPARATOR
Intervention: Large-volume paracentesis plus intravenous albumin (6-8 g/l ascites removed)
Number of subjects: 26
Study 1392697 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg i.v. infusion of alendronate over 2 hours (group A, n = 10)
Number of subjects: 20
Study 1392697 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg i.v. infusion of alendronate over 24 hours (group B, n = 10)
Number of subjects: 20
Study 1392697 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 20
Study 1392697 — intervention group
Group type: COMPARATOR
Intervention: Both treatments (A and B)
Number of subjects: 20
Study 3908126 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol 400-600 mg/day
Number of subjects: 45
Study 3908126 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25-50 mg/day
Number of subjects: 45
Study 31727642 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 225
Study 31727642 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum
Number of subjects: 225
Study 31727642 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetyl glucosamine
Number of subjects: 225
Study 31727642 — intervention group
Group type: EXPERIMENTAL
Intervention: Teduglutide
Number of subjects: 225
Study 31727642 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 225
Study 27885682 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluorescein (NaF) applied at various time points after AFXL exposure (0, 2, 5, 10, 30 minutes, 6, 24, and 48 hours)
Number of subjects: 11
Study 27885682 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluorescein (NaF) applied at 0, 2, 5, 10, and 30 minutes after AFXL exposure
Number of subjects: 11
Study 27885682 — intervention group
Group type: COMPARATOR
Intervention: Sodium fluorescein (NaF) applied later than 30 minutes after AFXL exposure
Number of subjects: 11
Study 27885682 — intervention group
Group type: COMPARATOR
Intervention: Optical coherence tomography (OCT) assessment of AFXL channel dimensions
Number of subjects: 11
Study 27885682 — intervention group
Group type: COMPARATOR
Intervention: Transepidermal water loss (TEWL) measurements
Number of subjects: 11
Study 25828624 — intervention group
Group type: EXPERIMENTAL
Intervention: Paleo diet
Number of subjects: 24
Study 25828624 — intervention group
Group type: COMPARATOR
Intervention: ADA diet
Number of subjects: 24
Study 23786651 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal Management Training with an errorless learning approach
Number of subjects: 32
Study 23786651 — intervention group
Group type: COMPARATOR
Intervention: Conventional Goal Management Training based on trial and error learning
Number of subjects: 32
Study 21857087 — intervention group
Group type: EXPERIMENTAL
Intervention: bezafibrate (200 mg twice daily)
Number of subjects: 73
Study 21857087 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3 fatty acids (1 g twice daily)
Number of subjects: 73
Study 21857087 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 73
Study 19215552 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (200 mg) on day 1 and vaginal misoprostol (800 microg) on day 3
Number of subjects: 100
Study 19215552 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol (800 microg) on days 1 and 3 (total dose 1600 microg)
Number of subjects: 100
Study 17126406 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar disorder (BP)
Number of subjects: 153
Study 17126406 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative discipline controls (CC)
Number of subjects: 153
Study 12582815 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h mixed AA co-infusion (120 g mixed AA: 26.4 g l-lysine + l-arginine)
Number of subjects: 24
Study 12582815 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-h mixed AA co-infusion (240 g mixed AA: 52.8 g l-lysine + l-arginine)
Number of subjects: 24
Study 12582815 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h Lys-Arg co-infusion (25 g each)
Number of subjects: 24
Study 12582815 — intervention group
Group type: COMPARATOR
Intervention: No infusion
Number of subjects: 24
Study 12582815 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-h mixed AA co-infusion
Number of subjects: 24
Study 10587340 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative aprotinin
Number of subjects: 617
Study 10587340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 617
Study 10163573 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 50 micrograms twice daily via Diskhaler
Number of subjects: 225
Study 10163573 — intervention group
Group type: COMPARATOR
Intervention: Sodium cromoglycate 20mg 4 times daily via spin operated dry powder inhaler
Number of subjects: 225
Study 1833610 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestradiol gel applied once/day on 800 cm2 of skin
Number of subjects: 0
Study 1833610 — intervention group
Group type: COMPARATOR
Intervention: Oestradiol patch applied for 3-5 days on 20 cm2 of skin
Number of subjects: 0
Study 6129673 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 410
Study 6129673 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 410
Study 6129673 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study 6129673 — intervention group
Group type: EXPERIMENTAL
Intervention: Favorable events
Number of subjects: 410
Study 6129673 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfavorable events
Number of subjects: 410
Study 6231043 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% lignocaine spray 2 ml
Number of subjects: 48
Study 6231043 — intervention group
Group type: COMPARATOR
Intervention: Halothane (0.5 or 1.5%) and thiopentone (4.5 or 10 mg kg‐1)
Number of subjects: 48
Study 6231043 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone (higher dose)
Number of subjects: 48
Study 6231043 — intervention group
Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 48
Study 6231043 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone (increased dose)
Number of subjects: 48
Study 31629326 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ program performed 3 times per week for 8 weeks
Number of subjects: 24
Study 31629326 — intervention group
Group type: COMPARATOR
Intervention: Regular warm-up program (Control)
Number of subjects: 24
Study 31629326 — intervention group
Group type: EXPERIMENTAL
Intervention: FIFA 11+ program
Number of subjects: 24
Study 29772114 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical instillation with highly concentrated hyaluronic acid/chondroitin sulphate (HA/CS)
Number of subjects: 92
Study 27079247 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate in 70% isopropyl alcohol
Number of subjects: 105
Study 27079247 — intervention group
Group type: COMPARATOR
Intervention: Routinely used chlorhexidine gluconate solutions
Number of subjects: 105
Study 24048369 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined prednisolone (20 mg/day) and LMW heparin (1 mg/kg/day) starting on the first day of ovarian stimulation and one day after oocyte retrieval, respectively.
Number of subjects: 334
Study 24048369 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 334
Study 23622992 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal Femoral Nail Antirotation (PFNA)
Number of subjects: 61
Study 23622992 — intervention group
Group type: COMPARATOR
Intervention: Gamma3 nail
Number of subjects: 61
Study 20307323 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking training at anaerobic threshold
Number of subjects: 60
Study 18705820 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day naloxone PR
Number of subjects: 202
Study 18705820 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day naloxone PR
Number of subjects: 202
Study 18705820 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day naloxone PR
Number of subjects: 202
Study 18705820 — intervention group
Group type: EXPERIMENTAL
Intervention: 2:1 dose ratio of oxycodone to naloxone
Number of subjects: 202
Study 18705820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 15925083 — intervention group
Group type: EXPERIMENTAL
Intervention: emergency extracorporeal shock wave lithotripsy (eESWL)
Number of subjects: 100
Study 15925083 — intervention group
Group type: COMPARATOR
Intervention: medical therapy alone
Number of subjects: 100
Study 12661534 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive counseling consisting of three 1-hour sessions
Number of subjects: 581
Study 12661534 — intervention group
Group type: COMPARATOR
Intervention: Routine counseling
Number of subjects: 581
Study 10857770 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (10000 U/kg body weight)
Number of subjects: 18
Study 10857770 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (1000 U/kg body weight)
Number of subjects: 18
Study 8642156 — intervention group
Group type: EXPERIMENTAL
Intervention: Competency Clinic assessment by a specially trained nurse in collaboration with a multidisciplinary team
Number of subjects: 96
Study 8642156 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatrician assessment using a decisional aid
Number of subjects: 96
Study 8642156 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic Instrument designed for any advance directive
Number of subjects: 96
Study 8642156 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific Instrument designed for the 'Let Me Decide' advance directive
Number of subjects: 96
Study 8642156 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized Mini‐Mental Status Examination (SMMSE)
Number of subjects: 96
Study 1499598 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine 0.2 mg non-fasting
Number of subjects: 18
Study 1499598 — intervention group
Group type: COMPARATOR
Intervention: Moxonidine 0.2 mg fasting
Number of subjects: 18
Study 6670341 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular, non medicamentous individual treatment in group A
Number of subjects: 141
Study 6670341 — intervention group
Group type: COMPARATOR
Intervention: Unique recommendation concerning preventive measures in group B
Number of subjects: 141
Study 31689832 — intervention group
Group type: EXPERIMENTAL
Intervention: Taoren Honghua Jian granule (THJG)
Number of subjects: 80
Study 31689832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 29204689 — intervention group
Group type: EXPERIMENTAL
Intervention: Adhesive patching
Number of subjects: 107
Study 29204689 — intervention group
Group type: COMPARATOR
Intervention: Over-glasses patching
Number of subjects: 107
Study 27484299 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stay group (2 months inpatient + biweekly visits for 4 months)
Number of subjects: 80
Study 27484299 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-stay group (6 months inpatient + 6 monthly return visits)
Number of subjects: 80
Study 27484299 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-stay group
Number of subjects: 80
Study 27484299 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-stay group
Number of subjects: 80